A method is described for determining the fraction of intestinal 3-0-methyl-glucose (30MG) absorption that occurs by active transport in chronically catheterized rats without the influence of anesthesia or surgical bowel manipulation. That fraction was determined by simultaneously measuring portal venous-aortic blood concentration gradients (AC) of 3-0-methyl-glucose (30MG) and L-glucose, metabolically inert analogues of D-glucose. 30MG is actively and passively absorbed by the same mechanisms as D-glucose. L-glucose is only passively absorbed. The fraction of 30MG that is actively transported was calculated from the difference between 30MG and L-glucose absorption, divided by total 30MG absorption. We found that more than 94% of 3-0-methyl-glucose is absorbed by active transport when luminal concentrations range from 50 to 400 mM. We conclude that in unrestrained, unanesthetized chronically catheterized rats, most 30MG is actively absorbed by the intestine even at high luminal concentrations. (J. Clin. Invest 1995. 95:2799-2805
Introduction
Previous studies of intestinal glucose absorption used models in which the intestine is acutely manipulated surgically either in vivo or during excision for in vitro experiments. Some of these studies claim that passive absorption of glucose by the intestine begins to exceed active transport at luminal glucose concentrations as low as 35-60 mM (1) (2) (3) (4) . The primary in vivo method for studying intestinal glucose transport has been the measurement of the rate of disappearance of glucose from the perfusate of a luminally perfused isolated loop of intestine in an anesthetized, acutely laparotomized animal (2, (5) (6) (7) (8) . In some studies, the intestinal vasculature is also perfused (9) (10) (11) . In vitro methods for studying intestinal glucose transport include everted sleeves of intestinal tissue (4, (12) (13) (14) , isolation of membrane vesicles (15) (16) (17) (18) , and cell cultures (19) .
Surgical bowel manipulation and anesthesia have many potential effects on the intestine including alterations of the unstirred water layer (20) , intestinal motility (21) , intestinal blood flow (22) , tissue hydrostatic pressure (23) (24) (25) , mucosal integrity, and cellular energy levels (26) . Therefore, it may not be appropriate to extrapolate the results obtained under these conditions to unanesthetized, nonlaparotomized animals (27) . Using a chronically catheterized rat model, we showed that portal venous and aortic blood concentrations of glucose after a gastric bolus increased at a slower rate immediately postoperatively compared to subsequent measurements (28) .
We developed a method to determine the fraction of intestinal 3-0-methyl-glucose (30MG)1 absorption that occurs by active transport under physiologic conditions in chronically catheterized rats. Using our model, we are able to measure the portal venous and aortic blood concentrations of L-glucose and 30MG after their infusion into the duodenal lumen. Because L-glucose and 30MG are not metabolized in the intestine, the rate of their appearance into the portal vein is equal to their rate of absorption from the intestinal lumen (9, 29, 30) . 30MG is actively transported by the same sodium-dependent cotransporter as D-glucose with a similar Vm. and Km ( 15, 31 ) . In this paper, we show that L-glucose absorption is similar to passive 30MG absorption. By comparing the relative net rate of appearance of 30MG and L-glucose into the portal vein, we calculated the fraction of intestinal 30MG absorption that is active.
This method offers many advantages over previous methods. Intestinal function can be studied in unanesthetized, unrestrained animals in a nonfasting state without the influence of surgical bowel manipulation. Because we measure the portal venous-aortic concentration gradients of total glucose absorption and its passive component simultaneously, various factors that affect the absorption of both components equally (such as the length of intestine exposed) do not change the relative fraction of total glucose absorption that is active. Each measurement of the relative contribution of passive and active transport can be performed in the same animal at the same time, thereby eliminating inter-animal and inter-experiment variability.
Using our chronically catheterized rat model without the influence of surgical bowel manipulation and anesthesia, we found that > 94% of intestinal 30MG absorption occurs by active transport at luminal 30MG concentrations ranging from 50 to 400 mM.
In the accompanying paper, we confirm the findings of this paper using a different method to measure intestinal glucose absorption in chronically catheterized rats and show that surgical bowel manipulation causes a 90% decrease in active glucose transport by the intestine (32) . Thus, the higher fraction of glucose absorption occurring by active transport found in this study is because our experiments are performed under conditions that are not influenced by surgical bowel manipulation.
Methods
Animals. Male Sprague-Dawley rats weighing 250-400 grams were obtained from Charles River Breeding Laboratories (Wilmington, MA). The rats were maintained under a 10:14 h light:dark cycle. Water and chow (Agway Rat Mouse Hamster Chow 3000) were available ad libitum except for the 4 h before an experiment when the animals were NPO.
Chemicals. All nonradioactive chemicals and reagents were obtained from Sigma Chemical Co (St. Louis, MO). All radioactive isotopes were obtained from DuPont-New England Nuclear Research Products (Boston, MA).
Operative procedures. The aortic and duodenal catheters were made by inserting a 0.5-cm tip of a 22-gauge Insyte catheter (Becton Dickinson Vascular Access, Sandy, UT) into a 3-cm segment of silastic tubing (ID = 0.03"; Baxter, McGaw Park, IL). A 0.5-cm segment of PE60 tubing (Clay Adams, Parsippany, NJ) was inserted into the other end of the silastic tubing. The catheters were then placed over 22-gauge Insyte needles. The portal venous catheter was made by inserting a 0.5-cm segment of PE60 tubing over both ends of a 6-cm segment of silastic tubing. This catheter was placed over a 22-gauge spinal needle.
The surgical procedure was performed under sterile conditions as previously described (28) . Briefly, male Sprague-Dawley rats were anesthetized with ketamine 60 mg/kg and xylazine 1.0 mg/kg IM. The abdomen and back were shaved and washed with ethanol and Betadine. A midline vertical incision was made from the xyphoid process to the suprapubic region, and a 1-cm skin incision was made over the cervical vertebrae. The tubing from three 3.5" intermittent infusion sets (Abbott Laboratories, North Chicago, IL) from which the butterfly needles had been previously removed were pulled through the cervical incision to the abdominal incision, and flushed with 0.9% saline containing 10 U heparin/ml. A vertical incision was then made in the abdominal wall, and the tubing introduced into the peritoneal cavity by making small punctures on the right side of the abdominal wall.
After retracting the intestines to the left onto sterile saline soaked gauze, the aortic catheter was introduced over the 22 gauge Insyte needle -0.5 cm into the aorta just distal to the renal arteries. The distal end of the catheter was inserted into one of the 3.5" infusion set tubings on the right side of the peritoneal cavity. into the duodenum. Experiments were performed at least 4 d postoperatively. This time frame was chosen because the rats were gaining weight and had reached at least 95% of their preoperative weight, and because studies described in the accompanying paper showed that the effects of surgical bowel manipulation were no longer present at this time (32) . The rats were NPO for 4 h before performing the studies.
In some rats, multiple experiments were performed. Since each experiment was performed at least 24 h apart and 30MG and L-glucose are not metabolized, there was minimal accumulation of isotope in the rat. In addition, we calculated the fraction of active transport from the change in the blood concentrations of 30MG and L-glucose as blood flows from the aorta into the portal vein and aorta and not on the absolute concentrations of L-glucose and 30MG. (6) In this study, we are measuring the fraction of 30MG that is active. Therefore, the portal venous-aortic concentration gradient of 30MG (AC30MG) is substituted for ACtow (15, 30) . L-glucose is absorbed only passively and has the same permeability coefficient as D-glucose (6, 29, 31, 33 We found that the ACLglUCOSe was 20±20 nmoles/gm blood (n = 6) and that the AC30MG in the presence of phloridzin was 30±60 nmoles/gm blood (n = 6). Because there was not a significant difference (P = 0.72), our assumption appears to be valid and the passive permeabilities of 30MG and L-glucose are similar, and the portal venous-aortic concentration gradient of L-glucose (ACLgluc,,) is equal to AC~uie
To measure total and passive transport simultaneously, phloridzin could not be used because it would block active transport. In addition, some investigators claim that since phloridzin inhibits the increase in tight junction permeability caused by activation of sodium coupled transport, it would also block the component of passive transport due to solvent drag (12, 35 The effect of dilution of duodenal infusions by luminal contents. An advantage of studying intestinal absorption using acute methods is that the luminal concentration of substrates can be measured or controlled. In chronically catheterized rats, infusions of substrates into the intestine may be diluted by luminal contents already present and, therefore, we cannot determine the exact luminal concentration of a substrate after it is infused into the intestine. To determine the extent that a duodenal infusion is diluted by luminal contents, we used seven rats to measure the factor by which a 1 ml bolus of 0.9% NaCl containing tracer quantities of [14C] polyethylene glycol (4 kD, 0.1 ,ICi/ ml) was diluted. These rats (preoperative weight 305.7±25.2) had two duodenal catheters placed. The surgical procedure was the same as above, but catheters were not placed in the aorta or the portal vein. The first duodenal catheter was introduced as described above. A second catheter, consisting of a 12" intermittent infusion set (Abbott Laboratories, North Chicago, IL) is the fraction of glucose absorption that occurs by active transport and is equal to (AC30MG -ACL-gUCOSse*)/AC30MG X 100%. Results are mean±SD.
from which the needle had been removed was inserted 1 cm distal to the initial duodenal catheter through a hole made in the intestine using an 18-gauge needle. This catheter was held in place with a purse string suture through the serosa using 5-O silk suture. Polyethylene glycol 4000 (PEG) was used in these experiments because most studies have found it not to be significantly absorbed by the rat small intestine (e.g., 38, 39, 40). Therefore, any decrease in the concentration of [ '4C] PEG is secondary to dilution from duodenal contents. One study claims that PEG may be absorbed by the intestine, but the absorption rate in that study was very slow, and was determined over a period of hours (7) . In contrast, our experiment was carried out over a period of - An inhibitor of active glucose transport, phloridzin, was added to the duodenal infusate as another method of determining the fraction of active transport. When 0.5 mM phloridzin was added to the duodenal infusion containing 100 mM 30MG with radiolabeled 30MG and L-glucose, the portal venous-aortic concentration gradient of 30MG was significantly decreased, and active transport decreased to 6±13% of total 30MG transport (Table II) .
Discussion
The relative amounts of active and passive 30MG absorption were measured in unrestrained, unanesthetized rats that were feeding and gaining weight at least 4 d postoperative. The fraction of luminal 30MG that is absorbed by active transport was determined by simultaneously measuring the portal venous-aortic blood concentration gradients of 30MG and L-glucose after a duodenal infusion of 30MG containing isotopes of 30MG and L-glucose in tracer quantities. Using this method, we showed that -94% of luminal 30MG is actively absorbed by the intestine even at concentrations as high as 400 M. As expected, the addition of phloridzin, an inhibitor of active glucose transport, blocked virtually all active transport and thus supported our conclusions. Thus, passive transport contributes little to total glucose absorption under physiological conditions.
Our method offers many advantages over previous methods. Each measurement of the relative contributions of passive and active transport was performed in the same rat at the same time after the same duodenal infusion, thereby eliminating inter-rat and inter-experiment variability. Intestinal function can be studied in unanesthetized, unrestrained animals in a nonfasting state.
By measuring the ratios of AC30MG and LXCL5glucOse* simultaneously, the resistance of the unstirred water layer, intestinal blood flow, dilution of intestinal contents, and length of intestine exposed is automatically the same for both.
C30MG and CL glucOse * in portal venous and aortic blood In this study, we determined the fraction of 30MG that is absorbed by active transport in the intestine by measuring the rate of its appearance in the portal vein. In contrast, most previous studies of intestinal glucose absorption using techniques such as perfusion of an isolate intestinal loop or everted sleeves measured the rate of disappearance of glucose from the lumen or mucosal surface (2, (4) (5) (6) (7) (8) (12) (13) (14) . Because 30MG is not metabolized or accumulated by the intestine, the rate of appearance of 30MG into the portal vein is equal to the rate of disappearance from the intestinal lumen (9) . Since D-glucose is metabolized by the intestine, the rate of appearance of D-glucose into the portal vein is less than is actually absorbed by the intestine (30, 41) .
The results of this study imply that the most D-glucose absorption also occurs by active transport. 30MG is actively transported at the brush border membrane by the major sodiumdependent transporter that transports D-glucose. Fedorak et al. showed that the Km for D-glucose and 30MG are similar but that the Vm,, was -30% less (15) . Thomson et al. showed that the rate of 30MG uptake in rats was 40% less than for Dglucose (33) . In addition, L-glucose accurately estimates the passive absorption of D-glucose (6, 29, 31, 33) . Thus, the fraction of D-glucose absorption that occurs by active transport is probably comparable to 30MG.
The results of this study are in conflict with those studies of intestinal glucose absorption that claimed that passive absorption begins to exceed active transport at luminal concentration of glucose as low as 35-60 mM (1) (2) (3) (4) . These studies used methods in which the intestine had been acutely manipulated surgically either in vivo or in vitro. Our study is consistent with a study in humans in vivo by Fine et al., who showed that 951% of glucose was actively absorbed at luminal glucose concentrations of 120 mM under conditions which avoid the effects of anesthesia and acute surgical bowel manipulation (42) . We speculate that the explanation for the lower fraction of active transport in those studies that conflict with our results is the adverse effects of surgical bowel manipulation and anesthesia on intestinal transport. In previous studies in rats by Kimura et al., there was a faster rate of increase in portal venous and aortic blood concentrations of glucose after a gastric infusion of glucose under chronic conditions in comparison with measurements immediately postoperative (28) . In the accompanying paper, we show that active transport of glucose by the intestine is decreased 90% immediately after laparotomy while passive absorption remains unaffected (32) . The possible mechanisms for this decrease in active transport of glucose are discussed in the accompanying paper.
Pappenheimer, Madara, and colleagues believe that the phenomenon of solvent drag, by which luminal solutes are passively absorbed by convection along with water, is the mechanism that enables the intestine to absorb large amounts of glucose despite low rates of active transport (5, 7, 12, 35, 43) . These investigators claim that paracellular transport secondary to solvent drag is enhanced by activation of sodium-coupled transport which causes dilation of paracellular channels (5, 7, 12, 35) . Since our studies were performed in the presence of 30MG, an activator of the sodium-coupled transport, paracellular channels should have been dilated and passive transport maximized ( 12, 37) . Despite activation of sodium-coupled transport, however, all passive mechanisms combined (including diffusion and solvent drag) were responsible for only 6% of 30MG absorption at a luminal concentration of 400 mM. In addition, the portal venous-aortic concentration gradient of L-glucose (ACL-g15cse * )
was not significantly different in the presence or absence of phloridzin (20±10 nmoles/gm without phloridzin vs 30±60 nmoles/gm with phloridzin, Table II ). Since phloridzin inhibits the increase in tight junction permeability caused by 30MG, if there is a significant increase in tight junction permeability caused by 30MG then ACLglucose * measured with phloridzin should have been less than when phloridzin was not present ( 12) . This lack of effect of phloridzin on permeability suggests that, under physiologic conditions, alteration of tight junction permeability does not contribute significantly to intestinal glucose absorption.
In addition, the fact that the portal venous-concentration gradients of 30MG with phloridzin, L-glucose in the presence of L-glucose alone, and L-glucose in the presence of 30MG Fine et al. showing that intestinal permeability to mannitol and L-xylose was not increased in the presence of D-glucose (42) .
In our chronically catheterized rat model, dilution of our duodenal infusion by intestinal contents may decrease the luminal concentrations of 30MG and L-glucose. However, we found that infusions into the duodenum were only diluted 15% (see Results). This dilution factor does not significantly change our results.
Using our method, we cannot accurately determine the length of intestine exposed to the infused substrate. Since we measured the portal venous-aortic concentration gradients of Lglucose and 30MG simultaneously after a single duodenal bolus, the same length of intestine was exposed to both L-glucose and 30MG. Regardless of how much intestine was exposed to the infusion, the relative proportion of active and passive absorption for intestinal glucose absorption would not change.
We conclude that most luminal 30MG is actively absorbed by the intestine under physiologic conditions. Since active transport greatly exceeds passive transport including both diffusion and solvent drag, it is apparent that solvent drag contributes minimally to glucose absorption in vivo under conditions which avoid the effects of acute surgical bowel manipulation and anesthesia. These results are similar to results in humans performed without the effects of laparotomy and anesthesia (42) .
